Skip Navigation


Nucleic Acids Research Advance Access originally published online on September 10, 2009
Nucleic Acids Research 2009 37(20):6681-6690; doi:10.1093/nar/gkp723
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (2511K) Freely available
Right arrow Screen PDF (1056K) Freely available
Right arrowOA All Versions of this Article:
37/20/6681    most recent
gkp723v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Dandrea, M.
Right arrow Articles by Palmieri, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dandrea, M.
Right arrow Articles by Palmieri, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2009, Vol. 37, No. 20 6681-6690
© The Author(s) 2009. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Gene Regulation, Chromatin and Epigenetics

MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines

Mario Dandrea1,2, Massimo Donadelli1, Chiara Costanzo1, Aldo Scarpa2 and Marta Palmieri1,*

1Department of Morphological and Biomedical Sciences, Section of Biochemistry and 2Department of Pathology, University of Verona, Verona, Italy

*To whom correspondence should be addressed. Tel: +39 045 8027169; Fax: +39 045 8027170; Email: marta.palmieri{at}univr.it

Received January 24, 2008. Revised August 11, 2009. Accepted August 16, 2009.

The aim of the present study was to analyse the molecular mechanisms involved in the Interleukin-6 (IL-6) silencing in pancreatic adenocarcinoma cell lines. Our results demonstrate that TNF-{alpha}, a major IL-6 inducer, is able to induce IL-6 only in three out of six cell lines examined. 5-aza-2'-deoxycytidine (DAC), but not trichostatin A (TSA), activates the expression of IL-6 in all cell lines, indicating that DNA methylation, but not histone deacetylation, plays an essential role in IL-6 silencing. Indeed, the IL-6 upstream region shows a methylation status that correlates with IL-6 expression and binds MeCP2 and H3meK9 only in the non-expressing cell lines. Our results suggest that critical methylations located from positions –666 to –426 relative to the transcription start site of IL-6 may act as binding sites for MeCP2.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.